About Gene Therapy, Jeff Galvin, CEO of AGT

CEO Jeff Galvin explains how American Gene Technologies uses genetic modifications in the body to change how viral diseases interact with the immune system

In this video, Jeff Galvin explains how American Gene Technologies (AGT) uses genetic modifications in the body to change how viral diseases interact with the immune system.

 

Jeff Galvin, CEO of AGT, explains how he believes gene therapy is developing in a similar way to that of computer software in the 1960’s. With the introduction of gene therapy, a vast number of diseases can be treated and cured in the not so distant future. Not only does this new toolset have the ability to perform better than traditional drugs, it also can do so at a fraction of the cost.

youtube-video-thumbnail

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!